Calyxt, Inc., a Minnesota-based company focusing on developing healthier food products, begins multi-location field trials in Argentina and in the U.S. of its high oleic/low trans fat soybean variety.
Calyxt has previously generated and validated the healthier, high oleic soybean oil in the greenhouse in its high-yielding germplasm. The initiation of these field trials after less than two years of trait development is an important milestone for Calyxt in the commercialization of healthier food products.
“The recent ban of trans fat products by the FDA positions Calyxt to become a major provider of the booming market of high oleic soybean oil. Initiating field trials of our new variety is a key milestone in Calyxt development that positions us among the leading companies of Agbiotech. Only a handful of companies are actually developing field validation of wholly owned products,” says Luc Mathis, chief executive officer of Calyxt, Inc.
